Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3019790 | Revista Española de Cardiología Suplementos | 2006 | 9 Pages |
Abstract
Since acute coronary syndrome results from coronary thrombosis, antiplatelet and anticoagulant drugs play a fundamental role in its treatment. Moreover, percutaneous coronary intervention, the preferred form of treatment in a large percentage of patients with this syndrome, is also a potent stimulator of platelet activation and blood coagulation. In this article, the mechanisms of platelet adhesion and aggregation and of blood coagulation are reviewed briefly. In addition, there is also a review of the antithrombotic drugs used in percutaneous coronary intervention, which includes their mechanisms of action, dosages, indications, and side-effects in patients with both stable and unstable coronary artery disease.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Dabit Arzamendi, Xavier Freixa, Maria Puig, Magda Heras,